2012 | | Pathologic diagnosis of recurrent glioblastoma: morphologic, immunohistochemical, and molecular analysis of 20 paired cases | 김보영, 김세혁, 김영배, 김장희, 신승수, 이기범, 이현우, 정선용, 한재호 |
2020 | | Predicting survival using the 2016 World Health Organization classification for anaplastic glioma | 노태훈 |
2018 | | Procarbazine and CCNU Chemotherapy for Recurrent Glioblastoma with MGMT Promoter Methylation | 김세혁 |
2015 | | Recurrent Glioblastomas Reveal Molecular Subtypes Associated with Mechanistic Implications of Drug-Resistance. | 김세혁, 우현구 |
2015 | | Romo1 is associated with ROS production and cellular growth in human gliomas. | 김세혁 |
2010 | | Stereological analysis on migration of human neural stem cells in the brain of rats bearing glioma. | 조경기 |
2020 | | Survival, Prognostic Factors, and Volumetric Analysis of Extent of Resection for Anaplastic Gliomas | 노태훈 |
2022 | | The efficacy of EGFR-tyrosine kinase inhibitor in non-small cell lung cancer patients with synchronous brain metastasis: a real-world study | 강석윤, 김세혁, 노오규, 노태훈, 신승수, 안미선, 오영택, 이현우, 최용원, 최진혁 |
2010 | | The growth of brain tumors can be suppressed by multiple transplantation of mesenchymal stem cells expressing cytosine deaminase. | 김성수, 김세중, 서해영, 유승완, 이영돈, 장다영, 조경기 |
2020 | | Treatment Results for Recurrent Glioblastoma and Alteration of Programmed Death-Ligand 1 Expression After Recurrence | 노태훈 |
2020 | | Tumor treating fields plus temozolomide for newly diagnosed glioblastoma: a sub-group analysis of Korean patients in the EF-14 phase 3 trial | 김세혁 |
2017 | | Underexpression of HOXA11 Is Associated with Treatment Resistance and Poor Prognosis in Glioblastoma | 김세혁, 우현구 |